BEHANDLUNG VON ADIPOZYTEN

European patent · EP3609500 · In force

Register entry

Publication number
EP3609500
Application number
EP18783870
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 9, 2018
Published
Feb 19, 2020
Granted
Nov 13, 2024
Protection ends at the latest
Apr 8, 2038
Next annual fee due
Apr 30, 2027
IPC classes
A61K 31/495 (2006.01)
A61K 31/505 (2006.01)
A61K 31/513 (2006.01)
C07D 239/08 (2006.01)
C07D 239/10 (2006.01)
C07D 239/22 (2006.01)
Priority
US 201762483584 P 10.04.2017
PCT application
PCT/US2018/026707 09.04.2018
PCT publication
WO2018/191166 18.10.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. Sep 24, 2025

    Change

    Published in Swissreg on 24.09.2025

  3. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  4. Nov 13, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.11.2024

Parties

Holder

Melior Pharmaceuticals I, Inc.

860 Springdale Drive Suite 500, Exton, PA 19341, US

Board of Supervisors of Louisiana State University and Agricultural and Mechanical College

3810 W. Lakeshore Drive, Baton Rouge, LA 70808, US

Inventor

REAUME, Andrew G.

Exton, Pennsylvania 19341, US

CONG, Weina

Exton, Pennsylvania 19341, US

GREENWAY, Frank

Baton Rouge, Louisiana 70808, US

COULTER, Ann

Baton Rouge, Louisiana 70808, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.